Tyme Technologies, Inc. Price Chart
Tyme Technologies, Inc. RFL.SG Financial and Trading Overview
| Tyme Technologies, Inc. stock price | 0.31 EUR |
| Previous Close | 0.31 EUR |
| Open | 0.32 EUR |
| Bid | 0.3 EUR x 0 |
| Ask | 0.32 EUR x 0 |
| Day's Range | 0.31 - 0.34 EUR |
| 52 Week Range | 0.21 - 0.89 EUR |
| Volume | 83 EUR |
| Avg. Volume | 92 EUR |
| Market Cap | 53.57M EUR |
| Beta (5Y Monthly) | 1.023044 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.13 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
RFL.SG Valuation Measures
| Enterprise Value | -23935646 EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.7160093 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Tyme Technologies, Inc. Stock Price History
| Beta (5Y Monthly) | 1.023044 |
| 52-Week Change | -64.52% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.89 EUR |
| 52 Week Low | 0.21 EUR |
| 50-Day Moving Average | 0.29 EUR |
| 200-Day Moving Average | 0.33 EUR |
RFL.SG Share Statistics
| Avg. Volume (3 month) | 92 EUR |
| Avg. Daily Volume (10-Days) | 8 EUR |
| Shares Outstanding | 172.21M |
| Float | 121.93M |
| Short Ratio | N/A |
| % Held by Insiders | 30.76% |
| % Held by Institutions | 7.51% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2022 |
| Most Recent Quarter (mrq) | June 30, 2022 |
| Next Fiscal Year End | March 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -15.70% |
| Return on Equity (ttm) | -28.35% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -24191816 EUR |
| Diluted EPS (ttm) | -0.13 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 77.11M EUR |
| Total Cash Per Share (mrq) | 0.45 EUR |
| Total Debt (mrq) | 26.49K EUR |
| Total Debt/Equity (mrq) | 0.04 EUR |
| Current Ratio (mrq) | 14.057 |
| Book Value Per Share (mrq) | 0.431 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -20214840 EUR |
| Levered Free Cash Flow (ttm) | -10932662 EUR |
Profile of Tyme Technologies, Inc.
| Country | Germany |
| State | NJ |
| City | Bedminster |
| Address | 1 Pluckemin Way |
| ZIP | 07921 |
| Phone | 212 461 2315 |
| Website | https://www.tymeinc.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 13 |
Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also developing TYME-19, an oral synthetic member of the bile acid family, which is in preclinical stage for the treatment of SARS CoV-2 diseases; and TYME-18, a CMBT compound that is in preclinical stage for the treatment of inoperable tumors. It has research collaborations with Mayo Clinic to perform in-depth analysis of pancreatic cancer cell gene expression, epigenetic, and metabolism changes from SM-88 treatment; and a research investigator at Georgetown University to examine the effects of SM-88 in breast cancer. The company was formerly known as Global Group Enterprises Corp. The company was incorporated in 2011 and is headquartered in Bedminster, New Jersey. As of September 16, 2022, Tyme Technologies, Inc. operates as a subsidiary of Syros Pharmaceuticals, Inc.
Q&A For Tyme Technologies, Inc. Stock
What is a current RFL.SG stock price?
Tyme Technologies, Inc. RFL.SG stock price today per share is 0.31 EUR.
How to purchase Tyme Technologies, Inc. stock?
You can buy RFL.SG shares on the Stuttgart exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Tyme Technologies, Inc.?
The stock symbol or ticker of Tyme Technologies, Inc. is RFL.SG.
How many shares does Tyme Technologies, Inc. have in circulation?
The max supply of Tyme Technologies, Inc. shares is 173.59M.
What is Tyme Technologies, Inc. Price to Earnings Ratio (PE Ratio)?
Tyme Technologies, Inc. PE Ratio is now.
What was Tyme Technologies, Inc. earnings per share over the trailing 12 months (TTM)?
Tyme Technologies, Inc. EPS is -0.13 EUR over the trailing 12 months.